ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,697,307, issued on Aug. 4, was assigned to STRM.bio Inc. (Cambridge, Mass.).
"Compositions and methods related to megakaryocyte-derived extracellular vesicles" was invented by Jonathan Thon (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions and methods related to megakaryocyte-derived extracellular vesicles derived from human pluripotent stem cells, where the megakaryocyte-derived extracellular vesicles may be utilized for drug delivery and treating various diseases."
The patent was filed on May 11, 2021, under Application No. 17/924,758.
*For further information, including images, charts and tables, plea...